BBLN, a protein with predominantly uncharted functions, serves as an instigator of CAMK2D autophosphorylation, leading to subsequent cardiac remodeling and failure in both humans and mice. The induction of BBLN is driven by hypoxia in TOF and/or pressure overload, as evidenced in mouse models.
References
van der Ven, J. P. G., van den Bosch, E., Bogers, A. J. C. C. & Helbing, W. A. F1000Res. 8, 1530 (2019).
Chowdhury, U. K. et al. J. Thorac. Cardiovasc. Surg. 132, 270–277 (2006).
Alipour Symakani, R. S. et al. Front Pediatr. 11, 1098248 (2023).
Pradegan, N. et al. Cardiovasc. Pathol. 25, 225–231 (2016).
Sukhacheva, T. V. et al. Cells 11, 175 (2022).
Raggi, F. et al. J. Transl. Med. 18, 21 (2020).
Kaynak, B. et al. Circulation 107, 2467–2474 (2003).
Mueller, A. S., McDonald, D. M., Singh, H. S. & Ginns, J. N. Heart Fail Rev 25, 583–598 (2020).
Abd Alla, J. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-023-00351-6 (2023).
Kushnir, A., Shan, J., Betzenhauser, M. J., Reiken, S. & Marks, A. R. Proc. Natl. Acad. Sci. USA 107, 10274–10279 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sperling, S.R. BLN protein induces cardiac hypertrophy and failure. Nat Cardiovasc Res 2, 964–965 (2023). https://doi.org/10.1038/s44161-023-00357-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00357-0
- Springer Nature Limited